The Finance Technology Research Centre (FTRC) has awarded a gold rating to 10 critical illness (CI) offerings this year.
The FTRC ratings are based on benchmarking the key features that advisers deem are the most relevant to consider when selecting the most appropriate CI cover for their clients.
Those awarded gold include Aviva Upgraded, Guardian, Legal & General Cix and Royal London Enhanced.
Adam Higgs, head of research adviser services at FTRC, said: “It’s great to see the number of critical illness product propositions achieving a gold rating this year as providers respond to significant changes and advancements in the market.
“A key differential to other comparison tools is the inclusion and specialist feedback from our panel of independent practicing medical practitioners.
“The benchmarking of each insurers’ definitions and establishing the likelihood of an adviser’s client being able to make a claim is a hugely valued resource by advisers.
“With medical science moving at such a fast pace, providers are continuing to improve the CI protection cover they offer, so the ratings and supporting services we provide are proving to be a vital resource for advisers to ensure they continue to be confident in recommending the most suitable cover for their clients.”
Rob Harvey, head of protection advice at IFA Drewberry, added: “The industry is increasingly competitive, particularly with many providers improving their CI propositions to stand out in what’s a fairly crowded marketplace.
“Having a well-respected body such as FTRC with their panel of medical experts providing a ranking of providers by the strength of their claims strategy, as well as their product features and overall propositions, is proving to be essential.
“Their services help to keep advisers up to date with developments, which in turn helps improve client outcomes.”